SCHEMBL7842384

SCHEMBL7842384

CCCn1c(-c2ccncc2)nn(CN2CCN(c3ccccc3OC)CC2)c1=S

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.53
DRD3 P35462 3/20 0.48
HTR1A P08908 3/20 0.47
PTK2 Q05397 1/20 0.47
PTGS2 P35354 1/20 0.46
ADRA1A P35348 3/20 0.46
ADRA1D P25100 2/20 0.44
DRD4 P21917 2/20 0.43
ADRA1B P35368 2/20 0.43
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
DRD5 P21918 1/20 0.42
HRH2 P25021 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR7 P34969 1/20 0.42
HRH1 P35367 1/20 0.42
HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843272 0.90 HTR1A (0.46) DRD2DRD3HTR1APTK2PTGS2
SCHEMBL7842937 0.88 PTK2 (0.50) DRD2DRD3HTR1APTK2ADRA1A
SCHEMBL7840038 0.87 PTK2 (0.46) DRD2DRD3HTR1APTK2ADRA1A
SCHEMBL7839816 0.80 ADRA1D (0.49) DRD2DRD3HTR1APTK2PTGS2
SCHEMBL7829462 0.78 DRD2 (0.47) DRD2DRD3PTK2ADRA1DDRD4
SCHEMBL7842760 0.77 HTR7 (0.48) DRD2DRD3PTK2ADRA1DDRD4
SCHEMBL7843951 0.75 PTK2 (0.48) DRD2DRD3HTR1APTK2PTGS2
SCHEMBL16887374 0.74 ALDH1A1 (0.49) DRD2DRD3HTR1APTK2ADRA1A
SCHEMBL7829698 0.74 HTR7 (0.47) DRD2DRD3PTK2PTGS2DRD4
SCHEMBL16875787 0.74 PTK2 (0.48) DRD2DRD3HTR1APTK2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839144-B1 PIPERAZINE DERIVATIVES AS THERAPEUTIC AGENTS KNOLL GMBH (DE) 2001-09-19 EP claimed
US-6114334-A CENTRAL NERVOUS SYSTEM DISORDERS KNOLL AKTIENGESELLSCHAFT (DE) 2000-09-05 US disclosed
EP-0839144-A1 PIPERAZINE DERIVATIVES AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003067-A1 PIPERAZINE DERIVATIVES AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed